✦ LIBER ✦

The Poly-pill: does it work and is chronic therapy acceptable?

✍ Scribed by A. S. Wierzbicki; R. Minhas

Book ID: 111309412
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 117 KB
Volume: 64
Category: Article
ISSN: 1368-5031
DOI: 10.1111/j.1742-1241.2010.02476.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene Therapy for Chronic Neuropathic Pai

Gene Therapy for Chronic Neuropathic Pain: How Does It Work and Where Do We Stand Today?

✍ Sanjeev Kumar; Rupam Ruchi; Stephen R. James; Elie J. Chidiac 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Antiplatelet therapy after endovascular

Antiplatelet therapy after endovascular intervention: Does combination therapy really work and what is the optimum duration of therapy?

✍ Richard V. Milani 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Does problem-based learning work? And wh

Does problem-based learning work? And whose fault is it if it doesn't? A response to the article by R. H. Glew

✍ Ian E. Hughes; Edward J. Wood 📂 Article 📅 2003 🏛 The American Society for Biochemistry and Molecula 🌐 English ⚖ 50 KB 👁 2 views

Glew [1] presents a dismal picture of problem-based learning (PBL) 1 as applied in some medical schools, but an equally grim picture could be presented of some more conventionally presented medical courses: hours spent memorizing minor details, little ability to make use of the information memorized

Is it possible to discontinue imatinib m

Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature

✍ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o

Incident acute coronary syndromes in chr

Incident acute coronary syndromes in chronic dialysis patients in the United States11The opinions are solely those of the authors and do not represent an endorsement by the Department of Defense or the National Institutes of Health. This is a U.S. Government work. There are no restrictions on its use.

✍ Trespalacios, Fernando C.; Taylor, Allen J.; Agodoa, Lawrence Y.; Abbott, Kevin 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 76 KB

## Background: Patients on dialysis have a disproportionately high rate of cardiovascular disease (cvd). however, the incidence and risk factors for incident acute coronary syndromes (acs) have not been previously assessed in dialysis patients. ## Methods: We analyzed the united states renal data